期刊文献+

N末端B型脑钠肽原的临床应用现状及其检验的注意事项 被引量:4

下载PDF
导出
摘要 N末端B型脑钠肽原(NT-ProBNP)是由心脏肌细胞分泌的目前认为无生理活性的一种肽类激素。但是它却是诊断心衰及其分级的一种金标准,并且对呼吸困难的鉴别具有良好的应用价值。在临床检验中一些问题也应特别注意,以便为临床提供准确可靠的实验结果。
作者 卢丰才
出处 《国际检验医学杂志》 CAS 2010年第10期1157-1159,共3页 International Journal of Laboratory Medicine
  • 相关文献

参考文献13

  • 1Sehou M,Gustafsson F,Nielsen PH,et al.Unexplained week-to-week variation in BNP and NT-proBNP is low in chronic heart failure patients during steady state[J].Eur J Heart Fail,2007,9(1):68-74.
  • 2Hogenhuis J,Voors AA,Jaarsma T,et al.Anaemia and renal dysfunction are independently associated with BNP and NT-proBNP levels in patients with heart failure[J].Eur J Heart Fail,2007,9(8):787-794.
  • 3Muscari M,Berzigotti A,Bianchi G,et al.Non-cardiac determinants of NT-proBNP levels in the elderly:Relevance of haematocrit and hepatic steatosis[J].Eur J Heart Fail,2006,8(8):468-476.
  • 4Pfister R,Diedrichs H,Schiedermair A,et al.Prognostic impact of NT-proBNP and renal function in comparison to contemporary multi-marker risk scores in heart failure patients[J].Eur J Heart Fail,2008,10(3):315-320.
  • 5Kremastinos DT,Tsiapras DP,Koustopoulou AG,et al.NT-proBNP levels and diastolic dysfunction in β-Thalassaemia major patients[J].Eur J Heart Fail,2007,9(5):531-536.
  • 6Cortés R,Rivera M,Salvador A,et al.Variability of NTproBNP plasma and urine levels in patients with stable heart failure:a 2-year follow-up study[J].Heart,2007,93(3):957-962.
  • 7陆齐,景宏美,秦晓同,袁鼎山,刘才旺.慢性心力衰竭患者脑钠肽水平与心功能的相关性[J].山东医药,2009,49(47):26-27. 被引量:20
  • 8潘秋红,诸茵茵,许妍.老年心力衰竭患者血浆脑钠肽水平变化及意义[J].山东医药,2009,49(15):62-62. 被引量:8
  • 9赵凤德.B型脑钠肽在心血管病中的临床价值[J].国际检验医学杂志,2006,27(10). 被引量:2
  • 10Paniagua R,Ventura MD,Avila-Díaz M,et al.NT-proBNP,Fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients[J].Nephrol Dial Transplant,2009,10(8):1093.

二级参考文献12

  • 1陈健(综述),陈辉(审校).脑利钠肽——心力衰竭的标志物[J].国际检验医学杂志,2007,28(6):564-565. 被引量:5
  • 2Groenning GA, Nilsson JC, Sondergaard L, et -M. Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations [ J ]. Eur J Heart Fail,2001,3(10) :699-708.
  • 3Latour-Perez J, Coves-Orts FJ, Abad-Terrado C, et al. Accuracy of B-type natriuretic peptide level in the diagnosis of left ventricular dysfunction and heart failure : a systematic review [J]. Eur J Heart Fail,2006,8(4) :390-399.
  • 4Burke MA,Cotts WG. Interpretation of B-type natriuretic peptide in cardiac disease and other comorbid conditions [J]. Heart Fail Rev, 2007,12( 1 ) :23-36.
  • 5Sudoh T, Kangawa K, Minamion N, et al. A new natriuretic peptide in porcine brain [J]. Nature,1988,322(3) :78-81.
  • 6Persson H, Lonn E, Edner M, et al. Diastolic dysfunction in heart failure with preserved systolic function : need for objective evidence : results from the CHARM Echocardiographic Substudy-CHARMES [J]. J Am Coil Cardiol,2007,49(6) :687-694.
  • 7Yan RT,White M ,Yan AT,et al. Usefulness of temporal changes in neurohonnones as markers of ventricular remodeling and prognosis in patients with left ventricnlar systolic dysfunction and heart failure re- ceiving either candesartan or enalapril or both [ J]. Am J Cardiol, 2005,96(5) :698-704.
  • 8Weber M, Hamm C. Role of B-type natriuretie peptide(BNP) and NT-proBNP in clinical routine [ J]. Heart,2006,92(6) :843-849.
  • 9Brenden CK, Hollander JE, Guss D, et al. Gray zone BNP levels in heart failure patients in the emergency department results from the rapid emergency department heart failure outpatient trial(REDHOT) multicenter study [J]. Am Heart J,2006,151 (5) :1006-1011.
  • 10Jourdain P,Jondeau G,Funck F,et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS- BNP Muhiccnter Study [J]. J Am Coll Cardiol,2007,49 (16): 1733-1739.

共引文献27

同被引文献27

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部